Tissue regeneration via multilineage differentiation

"Tissue regeneration via multilineage differentiation" is not a specific molecular target but rather describes a biological process by which certain types of **stem cells**—including human embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), mesenchymal stem/stromal cells (MSCs), and multilineage-differentiating stress-enduring (Muse) cells—are capable of differentiating into multiple specialized cell types from different germ layers. This property underpins their use in regenerative medicine to restore damaged tissues by generating new bone, cartilage, fat, muscle fibers with innervation potential, neurons, hepatocytes, and other specialized tissues. The process involves complex regulation by transcription factors such as Oct3/4, SOX2 and Nanog, signaling pathways including Wnt/BMP/Notch, and surface marker profiles that distinguish multipotent from pluripotent states. While these cellular therapies hold promise for treating conditions like musculoskeletal injuries, neurodegeneration, diabetes or heart failure, challenges remain regarding safety—including tumorigenicity—and ensuring precise control over lineage specification. This entry does not correspond to a single therapeutic target such as a receptor or enzyme but rather refers to an entire class of cellular processes central to regenerative medicine.

Other names

Tissue regeneration via multilineage differentiationMultilineage differentiation for tissue regenerationMultilineage-differentiating cells for tissue repair